ArticleNature communications2021
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1.
Xiaozhen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this paperpooled itcites it